Overall Score

Growth Durability

Revenue base remains small at an EV/Sales of 0.93x, but the business is still unprofitable with a net margin of -27.8% and operating margin of -30.9%.

Cash generation remains negative with free cash flow yield at -13.0% and operating cash flow yield at -18.9%, limiting self-funded growth.

Profitability

Gross margin is healthy at 66.0%, but that is not translating into operating leverage given EBIT margin of -34.1% and EBITDA margin of -30.6%.

Returns remain deeply negative, including ROIC of -25.8% and ROE of -43.3%, indicating weak capital efficiency.

Financial Strength

Liquidity is solid with a current ratio of 4.62x and quick ratio of 3.62x, providing near-term flexibility.

Leverage is manageable with debt-to-equity of 1.09x and net debt to EBITDA reported at -1.25x, but coverage metrics remain weak because earnings and cash flow are negative.

Reinvestment Capital Allocation

R&D intensity is modest at 12.6% of revenue and stock-based compensation is 12.5% of revenue, suggesting limited reinvestment capacity relative to the current loss profile.

Inventory intensity is high, with days inventory outstanding at 271 days and a cash conversion cycle of 271 days, which ties up working capital.

Valuation

The stock screens inexpensive on sales and book value, with price-to-sales at 0.55x and price-to-book at 0.94x.

However, valuation is constrained by negative earnings and cash flow, with price-to-free-cash-flow and price-to-operating-cash-flow both negative due to losses.